Company Profile

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX)
5:30 PM UTC, 07/03/24
Last: $0.58 Change: +0.00 %Change: +0.38% Volume: 12,206
Detailed Quote
Open: $ 0.61   Volume: 12,206
High: $ 0.61   Yield(%) 0.00
Low: $ 0.57   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 2.20M
EPS ($) -7.54   Shares Out: 3.80M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -19.87
% Price Change (last 13 weeks): -34.74
% Price Change (last 26 weeks): -88.06
% Price Change (last 52 weeks): -90.22
% Price Change (year to date): -88.18
Management Effectiveness
Return on Equity (%): -132.57
Return on Assets (%): -65.08
Return on Invested Capital (%): -276.29
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $0.70
200-day Moving Average: $2.74
Avg. Daily Vol. (last 50 days): 54,633
Avg. Daily Vol. (last 200 days): 218,492
52-wk high: $12.00
52-wk low: $0.57
Bid: $0.58
Ask: $0.60
Company Information
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Quoin Pharmaceuticals, Ltd.
42127 Pleasant Forest Court
Ashburn VA 20148-7349

Phone: 1.703.980.4182
Fax: n/a
http://www.quoinpharma.com
Per Share Data
Earnings (1year) ($): -7.54
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 5.74
Cash Flow ($): -8.67
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 0.85
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.15
Current Ratio (x): 3.15
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 0.00



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.